Browsing Tag
Dermatonics
2 posts
SkinBioTherapeutics (LSE: SBTX) is growing again, but will cash last long enough?
SkinBioTherapeutics is growing revenue, but cash and credibility remain tight. New FY2026 guidance will decide whether SBTX can rerate.
SkinBioTherapeutics partners with Umesh Modi Group for Dermatonics launch in AMEA
SkinBioTherapeutics plc (AIM: SBTX), a leading life science company focused on skin health, has announced a strategic partnership…